H.C. Wainwright Initiates Stemline Therapeutics With Buy
April 27, 2015 at 09:17 AM EDT
H.C. Wainwright initiated coverage on Stemline Therapeutics Inc (NASDAQ: STML) with a Buy rating. The target price for Stemline ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.